Choroidal osteoma and secondary choroidal neovascularization treated with ranibizumab

7Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

A 47-year-old female patient presented with a complaint of decreased vision in the right eye. Her visual acuity was 0.16 in the right eye and 1.0 in the left eye. Fundus examination revealed a slightly elevated, yellowish-white lesion with regular borders at the macula of the right eye. Early and late hyperfluorescence related with choroidal neovascularization (CNV) was detected in the right eye on fundus fluorescein angiography. B-scan ultrasonography revealed a hyperechoic choroidal lesion with acoustic shadowing. The lesion was diagnosed as choroidal osteoma. The patient received 3 injections of intravitreal ranibizumab. After 4 months, the visual acuity of the right eye was 0.9 and the CNV had regressed. Follow-up at about 7 months revealed reduced visual acuity in the right eye with an increase in subretinal fluid. An additional ranibizumab injection was administered. In this case report, we discuss the findings and treatment of a rare case of choroidal osteoma with secondary CNV.

Cite

CITATION STYLE

APA

Sezenöz, A. S., Bayar, S. A., & Yılmaz, G. (2017). Choroidal osteoma and secondary choroidal neovascularization treated with ranibizumab. Turk Oftalmoloiji Dergisi, 47(4), 243–246. https://doi.org/10.4274/tjo.86658

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free